JUBLINGREA - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.2
Show all parameters (20 more)
🧾 Chart Verdict
The stock is currently trading within a defined support zone around 625 ₹ to 610 ₹ (based on the recent low price and the 50 DMA). An entry point could be considered near 610 ₹, utilizing this level as a potential floor. A stop-loss order should be placed just below the 50 DMA at approximately 689 ₹ to mitigate downside risk. Overall, the momentum remains bullish, but prudent risk management is crucial given the elevated valuation and industry pressures.
✅ Positive
The price is currently holding above the 50 DMA and 200 DMA, indicating underlying support. Volume has been consistently high over the last week, suggesting strong interest in the stock, potentially signaling a continuation of the upward trend. The recent DII increase adds further momentum to this observation.
⚠️ Limitation
Despite the positive volume, the RSI reading of 26 suggests the stock is relatively undervalued compared to its historical range and the market as a whole. This could be a buying opportunity, but it’s important to acknowledge that a significant pullback remains possible if support fails. The high PEG ratio (9.48) relative to the industry PE (29.3) amplifies this concern, suggesting the stock is richly valued given its growth prospects.
📉 Company Negative News
Recent news indicates Jubilant Ingrevia reported a 32% YoY decline in net profit due to pricing pressures – This suggests headwinds affecting overall market sentiment and potentially impacting Jubilant’s share price if investors perceive similar challenges.
📈 Company Positive News
The stock has been featured on multiple brokerage radars, including Dixon Technologies, Meesho, and Amber Enterprises, indicating positive analyst attention which may provide a boost in investor confidence.
🏭 Industry
The pharmaceutical ingredients sector is currently experiencing moderate growth driven by increased demand for generic drugs and contract manufacturing services. The industry PE ratio of 29.3 closely mirrors Jubilant’s own valuation, suggesting a generally favorable environment for players like Jubilant Ingrevia – however, pricing pressures as seen in recent news could affect sector dynamics.